Demographics PCS SARS-CoV-2, convalescent ME/CFS Healthy
Group size (n) 30 30 16 30
Mean age in years (± SD) 38 (± 9) 35 (± 12) 41 (± 10) 34 (± 12)
Sex, female 73% 70% 75% 73%
Mean time between SARS-CoV-2 infection and study inclusion in days (± SD) 260 (± 104) 276 (± 142) - -
Asymptomatic/mild COVID-19 87% 93% - -
SARS-CoV-2 vaccination 67% 97% 75% 97%
Vaccinated before first SARS-CoV-2 infection 0% 40% - -